Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis.

Jiang, Kai; Xu, Yue; Wang, Dandan; Chen, Feng; Tu, Zizhuo; Qian, Jie; Xu, Sheng; Xu, Yixiang; Hwa, John; Li, Jian; Shang, Hongcai; Xiang, Yaozu

Jiang, Kai; Xu, Yue; Wang, Dandan; Chen, Feng; Tu, Zizhuo; Qian, Jie; Xu, Sheng; Xu, Yixiang; Hwa, John; Li, Jian; Shang, Hongcai; Xiang, Yaozu.

Affiliation

Jiang K; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Xu Y; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Wang D; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Chen F; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Tu Z; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Qian J; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Xu S; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Xu Y; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, East China University of Science and Technology, Shanghai, 200237, China.
Hwa J; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, CT, 06511, USA.
Li J; State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, East China University of Science and Technology, Shanghai, 200237, China.
Shang H; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
Xiang Y; Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China. yaozu.xiang@tongji.edu.cn.

Protein Cell ; 13(5): 336-359, 2022 05.

Article de En | MEDLINE | ID: mdl-33417139

Sujet(s)
Mots clés

NHE1; SGLT2 inhibitors; autosis; cardioprotection; empagliflozin; myocardial infarction

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète / Diabète de type 2 / Inhibiteurs du cotransporteur sodium-glucose de type 2 / Infarctus du myocarde Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Protein Cell Sujet du journal: BIOQUIMICA Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google